Bio-Path Holdings, Inc. (BPTH): R&D Expense
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$7.29M
Year ended 2024-12-31
$8.12M
Trailing 12 months to 2025-09-30
+7.3%
3-year compound annual growth
+9.7%
5-year compound annual growth
+16.2%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $7.29M | -37.2% | 2025-03-27, From 2024-01-01 |
| 2023-12-31 | $11.61M | +26.7% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $9.16M | +55.1% | 2024-03-07, From 2022-01-01 |
| 2021-12-31 | $5.91M | -10.2% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $6.58M | +43.5% | 2022-03-10, From 2020-01-01 |
| 2019-12-31 | $4.58M | -0.4% | 2021-03-09, From 2019-01-01 |
| 2018-12-31 | $4.60M | -16.0% | 2020-03-05, From 2018-01-01 |
| 2017-12-31 | $5.48M | +0.1% | 2019-03-19, From 2017-01-01 |
| 2016-12-31 | $5.47M | +81.3% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $3.02M | +85.3% | 2017-03-15, From 2015-01-01 |
| 2014-12-31 | $1.63M | +7.3% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $1.52M | +34.1% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $1.13M | n/a | 2015-03-16, From 2012-01-01 |